• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. LAPRA TY CLIP; CLIP, IMPLANTABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. LAPRA TY CLIP; CLIP, IMPLANTABLE Back to Search Results
Catalog Number MIC4034
Device Problems Positioning Failure (1158); Material Integrity Problem (2978)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/01/2022
Event Type  malfunction  
Event Description
It was reported that a patient underwent a cholecystectomy procedure in 2022 and clips sutures were used.During the procedure, the clips could not be taken from the cartridge using the applier.It was reported that the clips were picked manually and did not properly close.No adverse patient consequences were reported.No additional information was provided.
 
Manufacturer Narrative
Product complaint # (b)(4).Is not available for the initial report, a follow-up report will be filed as appropriate.Device analysis: twelve sterile reloads were returned for evaluation.Visual inspection and functional testing were conducted on the returned device.Visual analysis of the returned samples revealed that twelve mic4034 reloads were received with no apparent damage.The packages were opened and the reloads were tested for functionality with a test device for its functionality.Upon functional testing of the clips, the instrument loaded, retained, and deployed clips as intended.The clips were as intended and conform to our manufacturing requirements.As part of quality process, all devices are manufactured, inspected, and released to approved specifications.The event described could not be confirmed as the clips performed without any difficulties noted.Although no product defect was identified, there may have been other circumstances or issues that occurred during the use of the device that could not be replicated during the laboratory analysis.Ten sterile reloads were returned for evaluation.Visual inspection and functional testing were conducted on the returned device.Visual analysis of the returned samples revealed that ten mic4034 reloads were received with no apparent damage.The packages were opened and the reloads were tested for functionality with a test device for its functionality.Upon functional testing of the clips, the instrument loaded, retained, and deployed clips as intended.The clips were as intended and conform to our manufacturing requirements.As part of quality process, all devices are manufactured, inspected, and released to approved specifications.The event described could not be confirmed as the clips were performed without any difficulties noted.Although no product defect was identified, there may have been other circumstances or issues that occurred during the use of the device that could not be replicated during the laboratory analysis.Eighteen sterile reloads were returned for evaluation.Visual inspection and functional testing were conducted on the returned device.According to our analysis process, thirteen samples were taken randomly to be analyzed.Visual analysis of the returned samples revealed that thirteen mic4034 reloads were received with no apparent damage.The packages were opened and the reloads were tested for functionality with a test device for its functionality.Upon functional testing of the clips, the instrument loaded, retained, and deployed clips as intended.The clips were as intended and conform to our manufacturing requirements.As part of quality process, all devices are manufactured, inspected, and released to approved specifications.The event described could not be confirmed as the clips performed without any difficulties noted.Although no product defect was identified, there may have been other circumstances or issues that occurred during the use of the device that could not be replicated during the laboratory analysis.A manufacturing record evaluation was performed for the finished device lot, and no non-conformance's were identified.Events reported via: 2210968-2022-02260, 2210968-2022-02261, 2210968-2022-02262, 2210968-2022-02263, 2210968-2022-02259, 2210968-2022-02264, 2210968-2022-02265, 2210968-2022-02266, 2210968-2022-02267, 2210968-2022-02268, 2210968-2022-02270,2210968-2022-02271, 2210968-2022-02272, and 2210968-2022-02273.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LAPRA TY CLIP
Type of Device
CLIP, IMPLANTABLE
Manufacturer (Section D)
ETHICON INC.
1000 route 202
raritan NJ 08869
Manufacturer (Section G)
ETHICON INC.-GMBH
robert- koch strass1
norderstedt
GM  
Manufacturer Contact
elba bello
1000 route 202
raritan, NJ 08869
MDR Report Key13951269
MDR Text Key288209166
Report Number2210968-2022-02269
Device Sequence Number1
Product Code FZP
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K931492
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign
Reporter Occupation Other
Type of Report Initial
Report Date 03/30/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/30/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberMIC4034
Device Lot NumberRPBCQDQ0
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/24/2022
Date Manufacturer Received03/03/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured12/22/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-